Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 197

Similar articles for PubMed (Select 22285855)

1.

Distinct receptor subtypes mediate arginine vasopressin-dependent ACTH release and intracellular calcium mobilization in rat pituitary cells.

Perdonà E, Arban R, Griffante C.

Eur J Pharmacol. 2012 Mar 15;679(1-3):16-23. doi: 10.1016/j.ejphar.2012.01.003. Epub 2012 Jan 20.

PMID:
22285855
2.
3.

Oxytocin-stimulated release of adrenocorticotropin from the rat pituitary is mediated by arginine vasopressin receptors of the V1b type.

Schlosser SF, Almeida OF, Patchev VK, Yassouridis A, Elands J.

Endocrinology. 1994 Nov;135(5):2058-63.

PMID:
7956927
4.

Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4.

Cheng LL, Stoev S, Manning M, Derick S, Pena A, Mimoun MB, Guillon G.

J Med Chem. 2004 Apr 22;47(9):2375-88.

PMID:
15084136
6.

Characterization of a novel nonpeptide vasopressin V(2)-agonist, OPC-51803, in cells transfected human vasopressin receptor subtypes.

Nakamura S, Yamamura Y, Itoh S, Hirano T, Tsujimae K, Aoyama M, Kondo K, Ogawa H, Shinohara T, Kan K, Tanada Y, Teramoto S, Sumida T, Nakayama S, Sekiguchi K, Kambe T, Tsujimoto G, Mori T, Tominaga M.

Br J Pharmacol. 2000 Apr;129(8):1700-6.

7.

Position 4 analogues of [deamino-Cys(1)] arginine vasopressin exhibit striking species differences for human and rat V(2)/V(1b) receptor selectivity.

Guillon G, Pena A, Murat B, Derick S, Trueba M, Ventura MA, Szeto HH, Wo N, Stoev S, Cheng LL, Manning M.

J Pept Sci. 2006 Mar;12(3):190-8.

PMID:
16130178
8.

Vasopressin-induced intracellular Ca²⁺ concentration responses in non-neuronal cells of the rat dorsal root ganglion.

Moriya T, Kayano T, Kitamura N, Hosaka YZ, Asano A, Forostyak O, Verkhratsky A, Viero C, Dayanithi G, Toescu EC, Shibuya I.

Brain Res. 2012 Nov 5;1483:1-12. doi: 10.1016/j.brainres.2012.08.028. Epub 2012 Sep 6.

PMID:
22975133
9.

Vasopressin-binding sites in the pig pituitary gland: competition by novel vasopressin antagonists suggests the existence of an unusual receptor subtype in the anterior lobe.

Arsenijevic Y, Dubois-Dauphin M, Tribollet E, Manning M, Sawyer WH, Dreifuss JJ.

J Endocrinol. 1994 Jun;141(3):383-91.

PMID:
8071638
10.

Vasopressin-induced calcium signaling in cultured hippocampal neurons.

Brinton RD, Gonzalez TM, Cheung WS.

Brain Res. 1994 Oct 24;661(1-2):274-82. Corrected and republished in: Brain Res. 1994 Dec 19;667(1):151-9.

PMID:
7834378
11.

Effects of YM471, a nonpeptide AVP V(1A) and V(2) receptor antagonist, on human AVP receptor subtypes expressed in CHO cells and oxytocin receptors in human uterine smooth muscle cells.

Tsukada J, Tahara A, Tomura Y, Wada Ki, Kusayama T, Ishii N, Yatsu T, Uchida W, Taniguchi N, Tanaka A.

Br J Pharmacol. 2001 Jul;133(5):746-54.

12.

Arginine vasopressin and oxytocin increase intracellular calcium and cAMP in human glomerular epithelial cells in culture.

Späth M, Pavenstädt H, Petersen J, Schollmeyer P.

Kidney Blood Press Res. 1996;19(2):81-6.

PMID:
8871886
13.

Vasopressin and oxytocin receptors coupled to Ca2+ mobilization in rat inner medullary collecting duct.

Maeda Y, Han JS, Gibson CC, Knepper MA.

Am J Physiol. 1993 Jul;265(1 Pt 2):F15-25.

PMID:
8393622
14.

Evidence that the effects of arginine-8-vasopressin (AVP) on pituitary corticotropin (ACTH) release are mediated by a novel type of receptor.

Antoni FA, Holmes MC, Makara GB, Kárteszi M, László FA.

Peptides. 1984 May-Jun;5(3):519-22.

PMID:
6089144
15.

Effect of AVP and oxytocin on insulin release: involvement of V1b receptors.

Lee B, Yang C, Chen TH, al-Azawi N, Hsu WH.

Am J Physiol. 1995 Dec;269(6 Pt 1):E1095-100.

PMID:
8572202
16.

A V1-type receptor for mediating the neurohypophysial hormone-induced ACTH release in trout pituitary.

Pierson PM, Guibbolini ME, Lahlou B.

J Endocrinol. 1996 Apr;149(1):109-15.

PMID:
8676042
17.
18.

Characterization of receptors mediating AVP- and OT-induced glucagon release from the rat pancreas.

Yibchok-Anun S, Cheng H, Heine PA, Hsu WH.

Am J Physiol. 1999 Jul;277(1 Pt 1):E56-62.

19.

An overview of SSR149415, a selective nonpeptide vasopressin V(1b) receptor antagonist for the treatment of stress-related disorders.

Serradeil-Le Gal C, Wagnon J 3rd, Tonnerre B, Roux R, Garcia G, Griebel G, Aulombard A.

CNS Drug Rev. 2005 Spring;11(1):53-68. Review.

PMID:
15867952
20.

Characterization of a novel and selective V1B receptor antagonist.

Craighead M, Milne R, Campbell-Wan L, Watson L, Presland J, Thomson FJ, Marston HM, Macsweeney CP.

Prog Brain Res. 2008;170:527-35. doi: 10.1016/S0079-6123(08)00440-8.

PMID:
18655906
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk